In a recent study published in the British Medical Journal, researchers investigated the link between non-alcoholic fatty liver disease (NAFLD) in individuals with type 2 diabetes mellitus (T2DM) and ...

A recent cross-sectional study highlights the critical factors, such as lower education levels, high waist-to-hip ratios, and ...

HANGZHOU, China, Jan. 28, 2026 /PRNewswire/ -- Recently, the results of the pivotal Phase III clinical trial (EECOH-1) of ecnoglutide injection, developed by Sciwind Biosciences Co., Ltd. ("Sciwind"), ...

Liver stiffness and severe fibrosis, as measured by FibroScan, are independently linked to type 2 diabetes (T2DM) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), new ...

Fifty percent of T2DM patients also have NAFLD, confirmed via ultrasound, with elevated liver enzymes and altered lipid profiles. NAFLD and T2DM are key components of metabolic syndrome, sharing risk ...

Self-monitoring of blood glucose levels in patients with type 2 diabetes who are not treated with insulin did not improve glycemic control or health-related quality of life after one year in a ...

Compared with DPP4i, empagliflozin was associated with a lower risk of kidney- and cardiovascular-related outcomes in T2DM patients. Empagliflozin was found to significantly reduce the risk for kidney ...

The study found that thiazolidinediones, commonly used to treat individuals suffering from type 2 diabetes, activate the PPARY' receptors in the hypothalamus, which in turn triggers food hoarding, ...

Semaglutide associated with increased walking distance in patients with symptomatic peripheral artery disease and type 2 diabetes. (HealthDay News) — For patients with symptomatic peripheral artery ...

Effective prevention and management of type 2 diabetes can improve patient outcomes and reduce health care-related environmental impact.